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Borst).Frank Gerbode, the 53rd president of The American Asso-
ciation for Thoracic Surgery (AATS), was born in Placer-
ville, California, on February 3, 1907 (Figure 1).1,2 The
last of 4 children of Frank Albert Gerbode and Anna
Marie Leven, Gerbode was descended from German
immigrants who came to California during the Gold Rush
in the mid-1800s. Gerbode’s father started a construction
business, building several small factories, mining towns,
and sawmills in El Dorado County. His family moved to
Sacramento when Gerbode was 3 years old. Determined
to become a physician and to better his chances of being
admitted to a major university, he received permission
from his parents to move to San Francisco to live with his
older sister to complete his final 2 years of high school. Ger-
bode easily passed the college board examinations and at-
tended Stanford University, where he majored in
physiology. As an undergraduate working in the physiology
research laboratory, he began his lifelong passion in
biomedical research. After graduating with honors from
Stanford University and despite his father’s encouragement
for him to become a businessman, Gerbode began studying
at Stanford Medical School in San Francisco in 1932.
During medical school, Gerbode worked in the research
laboratory of Emile Holman (33rd AATS President).1,2 A
trainee of William Halsted, Holman had established a
national reputation as an investigator in the cardiovascular
system and, along with the neurosurgeon F. L. Reichart,
served as Gerbode’s mentor in his research and future
surgical endeavors. As a sophomore medical student,
convinced that the cardiovascular system was the next
great frontier in surgery, Gerbode chose to pursue a career
in surgery. He was awarded his medical degree from
Stanford in 1936 after completion of a general rotating
internship at Highland Hospital in Oakland. Strongly
encouraged by the Stanford surgeon Leo Eloesser (19th
AATS president), Gerbode continued his surgical training
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The Journal of Thoracic and CarFrom 1936 to 1937, recognizing the importance of
pathology training in becoming a surgeon, Gerbode studied
under the tutelage of Germany’s leading senior pathologist
Max Borst in Munich.1 Concurrent with his education in
pathology, Gerbode witnessed the troubling political
climate in Munich and the emergence of the Nazi Party,
manifested by their open military maneuvers in the city.
As the Nazi party expanded, including achieving control
of scientific institutions and hospitals, Gerbode became
aware of the harassment of Jews at that time and the
insidious development of what was to become the persecu-
tion of Jews and the creation of concentration camps,
notably Dachau outside of Munich. Because of his close
relationship with Gerbode, Borst at one point intimated
that his 10-year-old son Hans might be safer if Gerbode
took him back to the United States.1 This eventually was
not to be, but Gerbode maintained a lifelong relationship
with Hans and assisted with the latter’s subsequent medical
training at Harvard Medical School and as an intern at
Stanford Hospital. Hans Borst later became a highly distin-
guished professor and director of cardiothoracic surgery at
Hannover and was the first German honorary guest speaker
at the AATS annual meeting in 1985. While in Munich,
Gerbode was under constant surveillance by Nazi agents
and the German government. Notwithstanding, Gerbode
used his connections to help Jewish physicians immigrate
to the United States; one such physician was Samuel Engel,
who became a professor of ophthalmology at Stanford.
Gerbode returned to San Francisco to begin his surgery
residency at Stanford Hospital and to work with Holman
in the laboratory in 1937.1 His experiments were focused
on the treatment of cardiovascular disorders, such as patentdiovascular Surgery c Volume 146, Number 6 1317
Presidential Perspectives Bull and Fannductus arteriosus, coarctation, and mitral valve disease.
Gerbode served as the chief resident in surgery from 1939
to 1940, after which he joined the Stanford faculty as an
instructor in surgery. Gerbode considered himself fortunate
to be in surgery at ‘‘the right time,’’ because he was
engrossed in the developments in mitral surgery by such
pioneers as Elliott Cutler and Sir Henry Souttar.1
In 1942, duringWorldWar II (WWII), Gerbode, commis-
sioned as a major, was deployed to North Africa with the 45
other doctors and 52 nurses of the Stanford unit in the US
Army Medical Corps.1,2 Gerbode distinguished himself
with his surgical skills and coordination of the logistics of
the 59th Evacuation Hospital. This ‘‘mobile’’ hospital of
750 beds served in 6 major Army campaigns in WWII,
including those in North Africa, Sicily, Anzio, southern
France, central Europe, and Germany. In recognition of
his service, Gerbode was promoted to lieutenant colonel
and later received 6 combat medals and a unit citation.
From this experience, Gerbode learned 2 valuable and
pivotal lessons, specifically (1) the importance of
technical expertise in performing surgery at the highest
level, and (2) the importance of logistics and teamwork in
the delivery of complex surgical care. In 1945, Gerbode
was in southern Germany during its liberation by the
American forces. Returning to Munich, he was stunned by
the extent of the destruction. His saddest memory was
seeing Dachau the morning after it had been liberated;
the horrific scene at the concentration camp was deeply
life-changing.1 After WWII, he became a champion of
Jewish causes and a major contributor to the construction
of the statue commemorating the Holocaust near the Palace
of the Legion of Honor in San Francisco.
On his discharge from active duty in 1945, Gerbode
returned to Stanford Hospital in San Francisco.1,2 Because
his position as instructor in surgery had been eliminated
during the WWII, he, at the age of 38, faced the challenge
of building a surgical practice. Three milestones, namely
Gross’ description of the closure of a patent ductus
arteriosus in 1938, Crafoord’s repair of coarctation of the
aorta in 1944, and Blalock’s operation for the palliation of
cyanotic heart disease, also in 1944, would serve as
the foundation for a specialty focused on surgery of
the cardiovascular system. Gerbode thus returned to
the research laboratory to develop animal models of
congenital heart disease. Experience in the laboratory
furthered his technical ability and led Holman to ask for
his assistance with congenital operations. From his
experimental and clinical experience, ranging from the
acute effects of pulmonic and aortic stenosis on the
development of cardiac hypertrophy to the application of
novel vascular anastomoses in the treatment of
obstruction of the superior vena cava, Gerbode’s profile in
this new field of cardiovascular surgery began to rise.2,3
In 1949, he accepted a visiting professorship at St.1318 The Journal of Thoracic and Cardiovascular SurBartholomew’s Hospital in London, where he performed
the first patent ductus repair at that institution and a
variety of other congenital operations.
After his return to San Francisco in 1950, Gerbode
continued to advance the treatment of mitral stenosis.
Realizing the limitations of the finger fracture technique
of closed mitral valvotomy, he developed a valvulotome
designed to be passed through the ventricular apex.4,5 The
Gerbode valvulotome and the transventricular valvotomy
became widely used for closed mitral commissurotomy.
Because these closed procedures would always be limited
to a select subgroup of patients, performing open cardiac
surgical procedures in a safe and reproducible manner
required another scientific leap. Ultimately, because the
extracorporeal circuit was the essential component to
open heart surgery, Gerbode worked with John Osborn on
the development of a new heart-lung machine.1 In the
ensuing 18 months, Gerbode performed more than 300
open surgical procedures in the laboratory. In 1954, Gerbode
performed the first clinical open heart operation west of the
Mississippi, when he corrected an atrial septal defect using
his newly designed heart-lung machine. Gerbode’s research
team, including the engineer M. L. Bramson, went on to
make major contributions to the development of a
membrane oxygenator, a heat exchanger to allow cooling
and rewarming of the blood, and bypass circuits that reduced
injury to the red blood cells and platelets.1,2,6
During the Korean Conflict from 1950 to 1953, Gerbode
served as a lieutenant colonel in the army and a surgical
consultant at Oak Knoll Naval Hospital in Oakland,
California. At Oak Knoll, Gerbode operated on casualties
with major arterial injuries and worked with Frank Spencer
(63rd AATS President), while the latter was stationed at the
hospital.7,8 Spencer subsequently served in Korea and
began to repair arteries in the field, thereby forever
changing the concept of early repair of major vessels.1,9
In 1959, the Stanford Medical School was moved to the
university campus in Palo Alto. Despite offers of leadership
positions in the new institution, Gerbode elected to remain
in San Francisco.1,2 To maintain an environment of clinical
research and education, Gerbode co-founded the Institutes
of Medical Sciences (later known as the Medical Research
Institute of San Francisco or MRI) on the site of the old
Stanford Hospital. As director of the division of the Heart
Research Institute of MRI, he received funding from the
National Institutes of Health for research and training.
MRI became one of the 10 largest private research institutes
in the country, and Gerbode served as its president for 19
years and continuously as a trustee. He also began a clinical
fellowship to train surgeons in the specialty of cardiovascu-
lar surgery. He believed this was a global enterprise and that
training international surgeons would ensure the highest
standards of practice when these surgeons returned to their
home countries.1 Gerbode regarded his impact on surgicalgery c December 2013
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cardiac surgery, 63 went on to become service chiefs,
associate service chiefs, or professors of surgery. Professor
Borst noted,
Frank, as a representative of the leading nation in
cardiovascular surgery, felt a deep obligation to train
young academic surgeons around the globe. The fact
that he picked amultitude of fellowswho later became
leaders in his field bespeaks his intimate knowledge of
the international scene. I myself, like Frank, consider
this his greatest achievement, because his pupils learnt
from him not only cardiovascular curiosity and actual
surgery, but also the qualities of American academic
leadership, which they carried home (personal
communication, August 6, 2013).
In the early 1960s, in addition to his work in establishing
the research institutes, Gerbode secured funding for the
building of the Pacific Presbyterian Medical Center. During
the design of the new hospital, Gerbode collaborated with
IBM president Thomas Watson to develop the first compu-
terized hospital monitoring system in the United States.1,10
The major focus was the use of computers for patient
monitoring in the intensive care unit, with blood pressure,
heart rate, arterial blood gases, and pulmonary function
presented on a single monitor display. This project
involved the earliest applications of computers to clinical
medicine; its ongoing development was a major focus of
Gerbode’s for the remainder of his career. At his AATS
presidential address in 1973, Gerbode outlined the
development and future of computerized monitoring of
important physiologic parameters in a seriously ill patient,
a process that enabled more informed decision making
in patient care.10 He summarized his efforts by noting:
‘‘The seriously ill patient has many labile physiological
abnormalities which need to be monitored simultaneously
and frequently in order to guide his treatment intelligently.
It is our belief that this is best supplied by an on-line
computerized system. One has to have and use many
instruments to fly a complicated airplane through a storm
at night.’’10
Martha Alexander was born in Piedmont, California, in
1909, and graduated from Stanford University. The only
child of Wallace and Mary Alexander, Martha met Gerbode
in the experimental psychology class at Stanford, and they
were married in 1931 in his last undergraduate year.1
Devoted to her family and driven by an internal sense of
social responsibility, Martha was philanthropically
committed to nature and land conservation and the area of
personal choice.1,11 Land use, Planned Parenthood, and
the Young Women’s Christian Association (YWCA) took
on a new dimension with her financial support and
leadership. One of their sons, Wallace AlexanderThe Journal of Thoracic and CarGerbode, born in 1933, was 19 years old and a sophomore
at Stanford when he was killed in an automobile accident
near campus. The Gerbodes established the Wallace
Alexander Gerbode Foundation in his memory to benefit
projects in the Bay Area and in Hawaii.1 The foundation
has made contributions to the Nature Conservancy, civil
rights, minorities, and music and drama organizations.
Their daughter Maryanna noted, ‘‘Martha, through her
own financial and personal means, was able to achieve
what many nonprofits and corporations are today striving
to accomplish. Hopefully with some of her many
activities., future generations will realize the examples
she set during her lifetime of tenacity and dedication with
the heart of a true humanitarian.’’11 A very compassionate
and vibrant individual, Martha died in 1971. After
Gerbode’s retirement in 1980, he remained active as the
director of the Heart Research Institute and a board member
of MRI, the Pacific Medical Center, and the Gerbode
Foundation. In his free time, he enjoyed photography,
carpentry, sailing, skiing, duck hunting, and painting.
Gerbode died unexpectedly on December 6, 1984, and
was survived by 2 daughters, Maryanna and Penelope,
2 sons, Frank and Philip, and many grandchildren.
Gerbode’s 40 years in research, surgery and teaching have
been preserved in his writings, which include nearly 300
scientific manuscripts, monographs, and chapters.1,2
Gerbode made important contributions to the repair of
tetralogy of Fallot and endocardial cushion defects and was
among the first to describe the techniques of valvuloplasty
and annuloplasty in the correction of mitral valve
insufficiency. His writings span the breadth of the
development of cardiovascular surgery, not only the
technical description of surgical procedures, but also the
supporting infrastructure, including blood banking,
intensive care, and extracorporeal circulation. He helped to
standardize the dosing of protamine to neutralize the
heparin used during extracorporeal circulation and was the
first surgeon in the United States to use a volume respirator
during and after heart surgery. Additionally, Gerbode was
one of the first to promote the use of a median sternotomy
for cardiac surgery in contrast to the bilateral transverse
sternotomy.1,12 In 1958, he published a series of 5 patients
who had undergone successful surgical correction of left
ventricular to right atrial shunts; thereafter, a direct
communication between the left ventricle and the right
atrium became known as the Gerbode defect.13
Gerbode’s independence, self-confidence, generosity,
willingness to challenge established medical dogma, good
humor, and innovative mind made him uniquely suited to
be a pioneer in cardiovascular surgery. His colleague
J. Donald Hill reminisced, ‘‘My fondest memories of
Dr Gerbode are his optimism, his contemporary attitude
toward change, his will to be the best at what he did, and
his superb intraoperative judgment of knowing what willdiovascular Surgery c Volume 146, Number 6 1319
Presidential Perspectives Bull and Fannwork, combined with his technical mastery of carrying it
out. His legacy for young surgeons encompassed much
besides his being a generous benefactor of many public
and educational causes that will serve many people for
the years to come.’’2 Norman Shumway (67th AATS
president) once noted, ‘‘As Frank would say, ‘Life goes
on,’ so it is left for the rest of us to do our best and hope
that its performance will come close to the standard that
he established for us.’’1
We wish to thank J. Donald Hill, MD, Professor Hans Borst,
MD, and D. Craig Miller, MD, for their assistance in preparing
this profile.
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